, many different mutations at the HPRT gene locus (deletions, insertions, duplications, abnormal splicing, and point mutations at different sites of the coding region from exon I to 9) have been reported, including two rare cases in female subjects (Ogasawara et aL, 1989; Yamada et aL, I995a) . By potymerase chain reaction of r-everse-transcribed m R N A (RT-PCR) and the multiplex amplification technique of all nine H P R T exons from the genomic D N A coupled with direct sequencing, we identified H P R T mutants in Japanese (Yamada et al., 1992 (Yamada et al., , 1995a (Yamada et al., , 1996 and Korean (Choi et al., t993; Yamada et al., 1995b) . In this study, by the same means, we identified a new HPRT mutation in a Japanese family with Lesch-Nyhan syndrome.
The patient (13 mos) was suspected as having Lesch-Nyhan syndrome from the neurological manifestations with choreoathetosis, hyperuricemia (11.6 mg/dl), and hyperuricaciduria (46 mg/dl). H P R T activity was undetectable (<0.01, control v a l u e = 1.76+0.06 n m o l / m i n / m g hemoglobin) and adenine phosphoribosyl- 
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MoJecular analysis of a Japanese family with Lesch-Nyhan syndrome. (A) Direct sequencing of the HPRT genomic DNA from the father, the mother and the Lesch-Nyhan patient. The DNA fragments including exon 3 were amplified and were sequenced directly by the antisense primer HCB6, as described previously (Yamada et al., 1992) . (B) Family study by PCR-RFLP analysis. 234-bp DNA fragments were amplified using a sense primer HCA2 (Yamada et al., 1992) and an antisense primer HG3E2 (5r-AGTATGGTTTGCAGAG -ATTCAAAG-3'), digested by Mntl, and then agarose gel (1.5%) electrophoresis was carried out. The ~X174/HaelIl digest was used as DNA size markers. Closed triangles (,) pointed the position of the mutation and an allow (>) showed the proband.
transferase (APRT) activity (0.62 nmol/min/mg hemoglobin) was increased about 1.5-fold compared with the control value (0.43_+0.06) in the erythrocytes from the patient. We carried out the molecular analysis of HPRT gene in this Japanese LeschNyhan family. At first, the genomic DNA of the proband was analyzed. Multiplex amplification from genomic DNA (Yamada et at., 1992) revealed no differences in product sizes between the patient and the normal control (data not shown). By direct sequencing of all nine amplified exons, a single nucleotide substitution of T to C was detected in exon 3 (Fig. 1A) . No other change of the nucleotide sequence was detected on the entire coding region and on the region recognized for RNA splicing. RT-PCR amplification from mRNA isolated from the proband's peripheral blood resulted in a DNA fragment of the same size as that from the normal control. Direct sequencing analysis of the RT-PCR product showed a point mutation identical to that found in the genomic DNA. The substitution resulted in a mis-sense mutation, CTC (Leu) to CCC (Pro) at codon 65.
The MnlI restriction site (CCTC) in exon 3 is lost in the mutant allele (CCCC). A family study was thus performed by PCR-RFLP analysis utilizing this MnlI site (Fig. IB) . DNA fragments of 234 bp including exon 3 and intron 3 sequences were amplified using a sense primer HCA2 (on the exon 3, Yamada et al., 1992) and an antisense primer HG3E2 (on the intron 3, 5'-AGTATGGTTTG-CAGAGATTCAAAG-3'), from the genomic DNAs of the proband, the mother, the father and a normal control female volunteer. The fragment from the normal allele should be digested by MnlI to two bands of 198 and 36 bp. Analyses of the father and mother's samples showed the 198-bp band as the same as the normal control. Only the proband showed the 234-bp band from the mutant allele. Sequence analysis of the DNA fragments of the mother showed only normal T band at the mutation site (Fig. 1A) . Therefore, the mutation was a de novo event that had occurred in the germ cells of the mother or in the proband during the early phase of fetal development.
The mutation at codon 65 in this study (HPRTos,ka) can add a new information to over 50 different mis-sense mutations reported previously. This mutation (L65P) has not detected in any HPRT deficiencies previously, but we reported (Yamada et aL, 1992) that the single amino acid substitution of Ala (GCC) to Pro (CCC) at codon 64 caused Lesch-Nyhan syndrome (Case 2). In HPRTosak~, similar to in the Case 2, an increase in hydrophilicity and a change in secondary structure (a-helix to/3-sheet) were predicted by the analysis systems of the protein structure (GENETYX, 9.0), and no other change of the nucleotide sequence was detected. Furthermore, the identified substitution has never been detected as a polymorphism in over 100 other alleles. Therefore, it is suggested that the amino acid substitution of L65P in HPRTos~ka must affect the enzyme activity, although it is necessary to confirm by expression studies.
